Related Experiment Video
Updated: May 17, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
The Cul4A-DDB1 E3 ubiquitin ligase complex represses p73 transcriptional activity
M Malatesta1, A Peschiaroli, E M Memmi
1Department of Experimental Medicine and Surgery, University of Rome 'Tor Vergata', Rome, Italy.
Abstract:
The Cullin4A (cul4A)-dependent ligase (CDL4A) E3 has been implicated in a variety of biological processes, including cell cycle progression and DNA damage response. Remarkably, CDL4A exerts its function through both proteolytic and non-proteolytic events. Here, we show that the p53 family member p73 is able to interact with the CDL4A complex through its direct binding to the receptor subunit DNA-binding protein 1 (DDB1). As a result, the CDL4A complex is able to monoubiquitylate p73. Modification of p73 by CDL4A-mediated ubiquitylation does not affect p73 protein stability, but negatively regulates p73-dependent transcriptional activity. Indeed, genetic or RNA interference-mediated depletion of DDB1 induces the expression of several p73 target genes in a p53-independent manner. In addition, by exploiting a bioinformatic approach, we found that elevated expression of Cul4A in human breast carcinomas is associated with repression of p73 target genes. In conclusion, our findings add a novel insight into the regulation of p73 by the CDL4A complex, through the inhibition of its transcriptional function.
Insights
The Cullin4A (cul4A)-dependent ligase (CDL4A) complex monoubiquitylates p73, inhibiting its transcriptional activity. This discovery reveals a new regulatory mechanism for p73 and its target genes in processes like cancer.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The Cullin4A (cul4A)-dependent ligase (CDL4A) E3 complex is involved in crucial cellular processes, including cell cycle regulation and DNA damage response.
- CDL4A functions through both proteolytic and non-proteolytic mechanisms.
Purpose of the Study:
- To investigate the interaction between the CDL4A complex and the p53 family member p73.
- To elucidate the functional consequences of this interaction on p73 activity and gene expression.
Main Methods:
- Co-immunoprecipitation assays to demonstrate p73 binding to DNA-binding protein 1 (DDB1), a subunit of the CDL4A complex.
- Monoubiquitylation assays to assess the effect of CDL4A on p73.
- RNA interference (RNAi) and genetic depletion of DDB1 to study p73 target gene expression.
- Bioinformatic analysis of Cul4A expression in human breast cancer tissues.
Main Results:
- p73 directly binds to DDB1, facilitating its interaction with the CDL4A complex.
- The CDL4A complex monoubiquitylates p73 without affecting its protein stability.
- CDL4A-mediated ubiquitylation negatively regulates p73-dependent transcriptional activity.
- Depletion of DDB1 leads to increased expression of p73 target genes independently of p53.
- Elevated Cul4A expression in breast carcinomas correlates with repressed p73 target gene expression.
Conclusions:
- The CDL4A complex directly regulates p73 through monoubiquitylation.
- This regulation inhibits p73's transcriptional function, impacting gene expression.
- These findings provide novel insights into p73 regulation by the CDL4A complex and its implications in diseases like breast cancer.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Negative Regulator Molecules
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
DNA Damage can Stall the Cell Cycle

